New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place

Drug Metabolism and Disposition Volume 32 Issue 9

2013
- Volume 41
  - Issue 2 (Feb)
  - Issue 1 (Jan)
2012
- Volume 40
2011
- Volume 39
2010
- Volume 38
2009
- Volume 37
2008
- Volume 36
2007
- Volume 35
2006
- Volume 34
2005
- Volume 33
2004
- Volume 32
2003
- Volume 31
2002
- Volume 30
2001
- Volume 29
2000
- Volume 28
1999
- Volume 27
1998
- Volume 26
1997
- Volume 25

Bookmark
More Like This 7ft87IYS1b Preview Only

BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES

Simmonds, Andrea C.; Reilly, Christopher A.; Baldwin, R. Michael; Ghanayem, Burhan I.; Lanza, Diane L.; Yost, Garold S.; Collins, Kathy S.; Forkert, Poh-Gek

Follow Drug Metabolism and Disposition , Volume 32 (9): 1032 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004
Bookmark
More Like This f100fYQlTR Preview Only

CERAMIDE, AN APOPTOTIC RHEOSTAT, INHIBITS CCAAT/ENHANCER BINDING PROTEIN-β AND NF-E2-RELATED FACTOR-2 ACTIVATION: THE ROLE IN GLUTATHIONE S-TRANSFERASE A2 GENE REPRESSION

Park, I-Na; Cho, Il Je; Kim, Sang Geon

Follow Drug Metabolism and Disposition , Volume 32 (9): 893 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004
Bookmark
More Like This X0zeN8wk2h Preview Only

EFFECT OF PROTOTYPICAL INDUCING AGENTS ON P-GLYCOPROTEIN AND CYP3A EXPRESSION IN MOUSE TISSUES

Matheny, Christopher J.; Ali, Rabia Y.; Yang, Xiaodong; Pollack, Gary M.

Follow Drug Metabolism and Disposition , Volume 32 (9): 1008 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004
Bookmark
More Like This DQbvCPJPX7 Preview Only

SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM

Kulanthaivel, Palaniappan; Barbuch, Robert J.; Davidson, Rita S.; Yi, Ping; Rener, Gregory A.; Mattiuz, Edward L.; Hadden, Chad E.; Goodwin, Lawrence A.; Ehlhardt, William J.

Follow Drug Metabolism and Disposition , Volume 32 (9): 966 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004
Bookmark
More Like This Xz5KUBrFKT Preview Only

GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS

Donovan, Jennifer L.; Chavin, Kenneth D.; Devane, C. Lindsay; Taylor, Robin M.; Wang, Jun-Sheng; Ruan, Ying; Markowitz, John S.

Follow Drug Metabolism and Disposition , Volume 32 (9): 906 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004
Bookmark
More Like This sS6LFe4MZb Preview Only

CARRIER-MEDIATED UPTAKE OF H2-RECEPTOR ANTAGONISTS BY THE RAT CHOROID PLEXUS: INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 3

Nagata, Yoshinori; Kusuhara, Hiroyuki; Hirono, Shuichi; Endou, Hitoshi; Sugiyama, Yuichi

Follow Drug Metabolism and Disposition , Volume 32 (9): 1040 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004
Bookmark
More Like This MwlRZVDFKO Preview Only

CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES

Ramírez, Jacqueline; Innocenti, Federico; Schuetz, Erin G.; Flockhart, David A.; Relling, Mary V.; Santucci, Raymond; Ratain, Mark J.

Follow Drug Metabolism and Disposition , Volume 32 (9): 930 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004
Bookmark
More Like This LrMaBElAI2 Preview Only

ALTERED PHARMACOKINETICS OF OMEPRAZOLE IN CYSTIC FIBROSIS KNOCKOUT MICE RELATIVE TO WILD-TYPE MICE

Tallman, Melanie N.; Ali, Shazia Y.; Smith, Philip C.

Follow Drug Metabolism and Disposition , Volume 32 (9): 902 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004
Bookmark
More Like This mo0LjLK0i0 Preview Only

IN VITRO METABOLISM OF MK-0767 (±)-5-(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL-2-METHOXY-N-(4-TRIFLUOROMETHYL) PHENYLMETHYLBENZAMIDE, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES

Karanam, Bindhu V.; Hop, Cornelis E.C.A.; Liu, David Q.; Wallace, Mike; Dean, Dennis; Satoh, Hiroya; Komuro, Masakatsu; Awano, Katsuya; Vincent, Stella H.

Follow Drug Metabolism and Disposition , Volume 32 (9): 1015 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004
Bookmark
More Like This Osv536mUyr Preview Only

PHARMACOKINETICS AND METABOLISM OF TESAGLITAZAR, A NOVEL DUAL-ACTING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST, AFTER A SINGLE ORAL AND INTRAVENOUS DOSE IN HUMANS

Ericsson, H.; Hamrén, B.; Bergstrand, S.; Elebring, M.; Fryklund, L.; Heijer, M.; Öhman, K. P.

Follow Drug Metabolism and Disposition , Volume 32 (9): 923 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Drug Metabolism and Disposition Volume 32 Issue 9

BIOACTIVATION OF 1,1-DICHLOROETHYLENE TO ITS EPOXIDE BY CYP2E1 AND CYP2F ENZYMES

Simmonds, Andrea C.; Reilly, Christopher A.; Baldwin, R. Michael; Ghanayem, Burhan I.; Lanza, Diane L.; Yost, Garold S.; Collins, Kathy S.; Forkert, Poh-Gek

Follow Drug Metabolism and Disposition , Volume 32 (9): 1032 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

CERAMIDE, AN APOPTOTIC RHEOSTAT, INHIBITS CCAAT/ENHANCER BINDING PROTEIN-β AND NF-E2-RELATED FACTOR-2 ACTIVATION: THE ROLE IN GLUTATHIONE S-TRANSFERASE A2 GENE REPRESSION

Park, I-Na; Cho, Il Je; Kim, Sang Geon

Follow Drug Metabolism and Disposition , Volume 32 (9): 893 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

EFFECT OF PROTOTYPICAL INDUCING AGENTS ON P-GLYCOPROTEIN AND CYP3A EXPRESSION IN MOUSE TISSUES

Matheny, Christopher J.; Ali, Rabia Y.; Yang, Xiaodong; Pollack, Gary M.

Follow Drug Metabolism and Disposition , Volume 32 (9): 1008 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

SELECTIVE REDUCTION OF N-OXIDES TO AMINES: APPLICATION TO DRUG METABOLISM

Kulanthaivel, Palaniappan; Barbuch, Robert J.; Davidson, Rita S.; Yi, Ping; Rener, Gregory A.; Mattiuz, Edward L.; Hadden, Chad E.; Goodwin, Lawrence A.; Ehlhardt, William J.

Follow Drug Metabolism and Disposition , Volume 32 (9): 966 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

GREEN TEA (CAMELLIA SINENSIS) EXTRACT DOES NOT ALTER CYTOCHROME P450 3A4 OR 2D6 ACTIVITY IN HEALTHY VOLUNTEERS

Donovan, Jennifer L.; Chavin, Kenneth D.; Devane, C. Lindsay; Taylor, Robin M.; Wang, Jun-Sheng; Ruan, Ying; Markowitz, John S.

Follow Drug Metabolism and Disposition , Volume 32 (9): 906 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

CARRIER-MEDIATED UPTAKE OF H2-RECEPTOR ANTAGONISTS BY THE RAT CHOROID PLEXUS: INVOLVEMENT OF RAT ORGANIC ANION TRANSPORTER 3

Nagata, Yoshinori; Kusuhara, Hiroyuki; Hirono, Shuichi; Endou, Hitoshi; Sugiyama, Yuichi

Follow Drug Metabolism and Disposition , Volume 32 (9): 1040 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

CYP2B6, CYP3A4, AND CYP2C19 ARE RESPONSIBLE FOR THE IN VITRO N-DEMETHYLATION OF MEPERIDINE IN HUMAN LIVER MICROSOMES

Ramírez, Jacqueline; Innocenti, Federico; Schuetz, Erin G.; Flockhart, David A.; Relling, Mary V.; Santucci, Raymond; Ratain, Mark J.

Follow Drug Metabolism and Disposition , Volume 32 (9): 930 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

ALTERED PHARMACOKINETICS OF OMEPRAZOLE IN CYSTIC FIBROSIS KNOCKOUT MICE RELATIVE TO WILD-TYPE MICE

Tallman, Melanie N.; Ali, Shazia Y.; Smith, Philip C.

Follow Drug Metabolism and Disposition , Volume 32 (9): 902 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

IN VITRO METABOLISM OF MK-0767 (±)-5-(2,4-DIOXOTHIAZOLIDIN-5-YL)METHYL-2-METHOXY-N-(4-TRIFLUOROMETHYL) PHENYLMETHYLBENZAMIDE, A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST. I. ROLE OF CYTOCHROME P450, METHYLTRANSFERASES, FLAVIN MONOOXYGENASES, AND ESTERASES

Karanam, Bindhu V.; Hop, Cornelis E.C.A.; Liu, David Q.; Wallace, Mike; Dean, Dennis; Satoh, Hiroya; Komuro, Masakatsu; Awano, Katsuya; Vincent, Stella H.

Follow Drug Metabolism and Disposition , Volume 32 (9): 1015 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

PHARMACOKINETICS AND METABOLISM OF TESAGLITAZAR, A NOVEL DUAL-ACTING PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR α/γ AGONIST, AFTER A SINGLE ORAL AND INTRAVENOUS DOSE IN HUMANS

Ericsson, H.; Hamrén, B.; Bergstrand, S.; Elebring, M.; Fryklund, L.; Heijer, M.; Öhman, K. P.

Follow Drug Metabolism and Disposition , Volume 32 (9): 923 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Advanced Filters:

Specific Data Sources:

Drug Metabolism and Disposition Volume 32 Issue 9

1 - 10 of 24 articles

Simmonds, Andrea C.; Reilly, Christopher A.; Baldwin, R. Michael; Ghanayem, Burhan I.; Lanza, Diane L.; Yost, Garold S.; Collins, Kathy S.; Forkert, Poh-Gek

Follow Drug Metabolism and Disposition , Volume 32 (9): 1032 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Park, I-Na; Cho, Il Je; Kim, Sang Geon

Follow Drug Metabolism and Disposition , Volume 32 (9): 893 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Matheny, Christopher J.; Ali, Rabia Y.; Yang, Xiaodong; Pollack, Gary M.

Follow Drug Metabolism and Disposition , Volume 32 (9): 1008 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Kulanthaivel, Palaniappan; Barbuch, Robert J.; Davidson, Rita S.; Yi, Ping; Rener, Gregory A.; Mattiuz, Edward L.; Hadden, Chad E.; Goodwin, Lawrence A.; Ehlhardt, William J.

Follow Drug Metabolism and Disposition , Volume 32 (9): 966 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Donovan, Jennifer L.; Chavin, Kenneth D.; Devane, C. Lindsay; Taylor, Robin M.; Wang, Jun-Sheng; Ruan, Ying; Markowitz, John S.

Follow Drug Metabolism and Disposition , Volume 32 (9): 906 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Nagata, Yoshinori; Kusuhara, Hiroyuki; Hirono, Shuichi; Endou, Hitoshi; Sugiyama, Yuichi

Follow Drug Metabolism and Disposition , Volume 32 (9): 1040 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Ramírez, Jacqueline; Innocenti, Federico; Schuetz, Erin G.; Flockhart, David A.; Relling, Mary V.; Santucci, Raymond; Ratain, Mark J.

Follow Drug Metabolism and Disposition , Volume 32 (9): 930 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Tallman, Melanie N.; Ali, Shazia Y.; Smith, Philip C.

Follow Drug Metabolism and Disposition , Volume 32 (9): 902 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Karanam, Bindhu V.; Hop, Cornelis E.C.A.; Liu, David Q.; Wallace, Mike; Dean, Dennis; Satoh, Hiroya; Komuro, Masakatsu; Awano, Katsuya; Vincent, Stella H.

Follow Drug Metabolism and Disposition , Volume 32 (9): 1015 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004

Ericsson, H.; Hamrén, B.; Bergstrand, S.; Elebring, M.; Fryklund, L.; Heijer, M.; Öhman, K. P.

Follow Drug Metabolism and Disposition , Volume 32 (9): 923 Am. Soc for Pharma & Experimental Therapeutics – Sep 1, 2004